Cargando...
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer
OBJECTIVE. To evaluate the utility of amiodarone and its derivative dronedarone as novel drug repositioning candidates in EOC and to determine the potential pathways targeted by these drugs. METHODS. Drug-predict bioinformatics platform was used to assess the utility of amiodarone as a novel drug-re...
Gardado en:
| Publicado en: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6526024/ https://ncbi.nlm.nih.gov/pubmed/30301560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.09.019 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|